The PhRMA Foundation seeks to invest in equity-focused research on the use of digital health technologies (DHTs) to improve participation of underrepresented populations in clinical trials. Learn more and apply. | | |
Q&A with FDA Chief Scientist and PhRMA Foundation Alumna Dr. Namandjé Bumpus
Namandjé N. Bumpus, PhD, is approaching her one-year anniversary as Chief Scientist at the Food and Drug Administration (FDA). But long before she was named to this high-profile role, Bumpus received two PhRMA Foundation awards. In this Q&A, she discusses how the Foundation awards impacted her career, her commitment to mentoring the next generation of scientists, her views on what it means to be a leader, and what her FDA role entails. Read the Q&A.
| | |
From Health Policy Expert to Patient
In a new blog series, PhRMA Foundation President Amy M. Miller, PhD, shares her experiences with eosinophilic esophagitis (EoE) and her health policy concerns from the perspective of a rare disease patient.
| | |
Exploring the Impact of the Inflation Reduction Act
In the first blog, Dr. Miller shares her experiences as an EoE patient and her concerns that policy provisions in the Inflation Reduction Act could make it less likely for new drugs to reach patients like her. Read more.
The Perils of Navigating Insurance
In the second blog, Dr. Miller explores insurance challenges that are emblematic of rare disease patient experiences and the unintended consequences of a convoluted policy framework not designed with the patient in mind. Read more.
| | |
The PhRMA Foundation awarded 42 researchers a total of more than $3 million in 2023 fellowships and grants. Learn about some of these researchers and their projects in the interviews below. | | |
Dr. Ashlee Brunaugh: Designing Inhaled Drugs to Overcome Antibiotic Resistance | | |
Antimicrobial resistance is a top 10 global public health threat, according to the World Health Organization. Ashlee Brunaugh, PhD, PharmD, of the University of Michigan aims to overcome this resistance by developing novel inhaled therapeutics to treat bacterial lung infections. Watch now. | | |
Jacqueline Plau: Developing a Therapeutic Strategy for Blinding Eye Diseases | | |
In this blog, Jacqueline Plau, a PhD student at Case Western Reserve University, describes her research to advance therapies for currently untreatable eye diseases and the many surprises that science can hold. Read the Q&A. | | |
Kinza Rizwan: Exploring a Novel Therapeutic Target for Prostate Cancer | | |
After emigrating from Pakistan to the U.S. at age 12, Kinza Rizwan worked tirelessly to become the first member of her family to attend college. Now a graduate student at Baylor College of Medicine, she is researching a potential therapeutic target for prostate cancer, the second-leading cause of cancer-related death in men. Learn more. | | |
Aakanksha Rajiv Kapoor: Working to Improve the Efficacy of Immunotherapy for Lung Cancer
As a graduate student at Weill Cornell Medicine, Aakanksha Rajiv Kapoor is working in a lab studying lung cancer, the leading cancer killer for women and men in the U.S. Her goal is to find ways to use the body's own immune system to help in the treatment of lung cancer. Learn more.
| |
| |
|
Albert Agustinus of Weill Cornell Medicine will be a speaker for the Gordon Research Symposium on Chromosome Dynamics in June and Gordon Research Symposium on Cell Growth and Proliferation in July.
Asmi Chakraborty, PhD, recently began a new job as a scientist with Palleon Pharmaceuticals.
Leora Goldbloom-Helzner presented her project, "What They Don't Teach You in Grad School: Resources and Support for Starting an Academic Laboratory," for UC Davis's Professors for the Future Program.
Wonjo Jang completed his MD/PhD training at the Medical College of Georgia and will join Mass General Brigham Neurology Residency at Harvard Medical School.
Meng Li, ScM, PhD, of the University of Texas MD Anderson Cancer Center received a grant from the Leukemia & Lymphoma Society Equity in Access Program.
Vladimir Molchanov is organizing the Van Andel Institute's 2023 Bioinformatics Workshop on July 27. Register here.
William Padula, PhD, of the University of Southern California recently published the "Handbook of Applied Health Economics for Vaccines."
Claire Shudde of the University of Michigan presented her poster, "A STAT5 activator protects CD8+ T cells in immunosuppressive environments," at the American Association of Immunologists conference in May.
Eline van den Broek-Altenburg, PhD, of the University of Vermont will present her Foundation-funded work at two upcoming conferences:
- "Drivers of Health Disparities and Consequences for COVID-19 Vaccine Choices: Modelling Health Preference Heterogeneity Among Underserved Populations," 15th World Congress of the International Health Economics Association
- "Patient Preferences for Diagnostic Imaging Services: Blueprint for Value-Based Incentives Incorporating Individual Preference Heterogeneity," AcademyHealth
Several awardees presented posters at the American Association for Cancer Research Annual Meeting in April:
-
Aakanksha Rajiv Kapoor of Weill Cornell Medicine, "Immunoregulatory role of club cell secretory proteins in non-small cell lung cancer"
-
Dallin Lowder of Baylor College of Medicine, "Developing a lipogenesis inhibitor for prostate cancer"
-
Kinza Rizwan of Baylor College of Medicine, "SPOP loss places the prostate luminal epithelial cells at a selective disadvantage"
|  |
| |
Congrats to these Foundation-funded researchers on their recent work. |
| |
*Indicates research directly funded by a PhRMA Foundation award | | |
Did someone forward this to you? Subscribe to get updates and funding announcements directly in your inbox. | | | | | | |
